DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 168 filers reported holding DIPLOMAT PHARMACY INC in Q2 2016. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $104,000 | -83.7% | 26,026 | -80.0% | 0.00% | -100.0% |
| Q3 2019 | $638,000 | -22.7% | 130,151 | -4.0% | 0.00% | 0.0% |
| Q2 2019 | $825,000 | +10.4% | 135,518 | +5.4% | 0.00% | 0.0% |
| Q1 2019 | $747,000 | -38.4% | 128,520 | +42.6% | 0.00% | 0.0% |
| Q4 2018 | $1,213,000 | -17.1% | 90,102 | +19.5% | 0.00% | 0.0% |
| Q3 2018 | $1,463,000 | +61.8% | 75,393 | +113.1% | 0.00% | 0.0% |
| Q2 2018 | $904,000 | +107.3% | 35,385 | +63.5% | 0.00% | – |
| Q1 2018 | $436,000 | -69.9% | 21,643 | -70.0% | 0.00% | -100.0% |
| Q4 2017 | $1,448,000 | -43.8% | 72,168 | -42.0% | 0.00% | -50.0% |
| Q3 2017 | $2,577,000 | -13.8% | 124,426 | -38.4% | 0.00% | -33.3% |
| Q2 2017 | $2,988,000 | +81.9% | 201,887 | +96.1% | 0.00% | +200.0% |
| Q1 2017 | $1,643,000 | +49.8% | 102,973 | +18.3% | 0.00% | 0.0% |
| Q4 2016 | $1,097,000 | +5994.4% | 87,043 | +13629.2% | 0.00% | – |
| Q3 2016 | $18,000 | -52.6% | 634 | -41.1% | 0.00% | – |
| Q2 2016 | $38,000 | -94.7% | 1,076 | -95.9% | 0.00% | -100.0% |
| Q1 2016 | $723,000 | +2026.5% | 26,393 | +2539.3% | 0.00% | – |
| Q4 2015 | $34,000 | +88.9% | 1,000 | +57.5% | 0.00% | – |
| Q3 2015 | $18,000 | -40.0% | 635 | -5.2% | 0.00% | – |
| Q2 2015 | $30,000 | -26.8% | 670 | -43.9% | 0.00% | – |
| Q1 2015 | $41,000 | -50.0% | 1,194 | -60.0% | 0.00% | – |
| Q4 2014 | $82,000 | – | 2,985 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|